Ethiopia

in page functions
[French]
Ethiopia
Total population (2017) 104,344,587
Birth cohort (2017) 3,230,017
Surviving Infants (surviving to 1 year per year, 2017) 3,090,741
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 41/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 59/1000
World Bank Index, IDA (2015) 3.49
Gross Nation Income (per capita US$, 2015) 590
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 840

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Ethiopia

Type of support

Approvals

2001-2022 (US$)
(28 Mar 2018)

Commitments

2001-2022 (US$)
(28 Mar 2018)

Disbursements

2000-2018 (US$)
(28 Mar 2018)

% Disbursed

(28 Mar 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $965,742,370 $1,231,762,056 $940,660,200
Cash Support (CASHSUPP) $170,000 $195,000 $170,000 100%
Civil Society Organisation support (CSO) $3,320,000 $3,320,000 $3,420,000 103%
Cold Chain Equipment Optimisation Platform (CCEOP) $4,747,678 $20,875,664
Health system strengthening (HSS 1) $76,493,935 $76,493,935 $76,493,935 100%
Health system strengthening (HSS 2) $61,410,682 $61,410,682 $61,410,682 100%
Health system strengthening (HSS 3) $34,540,000 $80,590,000 $34,540,000 100%
HPV (NVS) $12,659,500 $40,478,500
HPV Demo (NVS) $147,439 $147,439 $147,439 100%
HPV MAC (NVS) $50,803,000 N/A
HPV MAC - Op costs (OPC) $4,195,200 N/A
Immunisation services support (ISS) $23,445,320 $23,445,320 $17,813,320 76%
Injection Safety Devices (NVS) $2,276,655 $5,626,155 $2,737,506 120%
Injection safety support (INS) $2,696,697 $2,696,697 $2,696,697 100%
IPV (NVS) $10,426,463 $10,426,463 $7,748,774 74%
Measles 1st and 2nd dose (NVS) $714,500 $1,954,500
Measles SIA (NVS) $8,458,031 $8,458,031 $8,458,031 100%
Measles SIA - Operational costs (OPC) $15,263,500 $15,263,500 $15,075,741 99%
Meningitis A - campaign (NVS) $43,030,647 $43,030,647 $44,310,479 103%
Meningitis A - operational costs (OPC) $37,950,270 $37,950,270 $34,028,741 90%
Penta (NVS) $236,504,887 $255,927,887 $235,764,116 100%
Pneumo (NVS) $309,645,911 $380,731,411 $325,426,535 105%
Rotavirus (NVS) $70,212,485 $96,113,985 $61,971,436 88%
Vaccine Introduction Grant (VIG) $11,627,770 $11,627,770 $8,446,768 73%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Ethiopia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 96%
M:F sex ratio at birth (2017) 1.04
Household survey: DTP3 coverage for male (2010) 34.30%
Household survey: DTP3 coverage for female (2010) 38.80%
Household survey: Last DTP3 survey (2010) 37%
% districts achieving > 80% DTP3 coverage (2016) 76%
% districts achieving < 50% DTP3 coverage (2016) 7%
MCV WHO/UNICEF estimates (2016) 70%

Breakdown of support

Non-vaccine support Vaccine support
27% 73%
$254,095,884 $686,564,316

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Ethiopia

09 January 2018

IFFIm Chair - René Karsenti and Cyrus Ardalan

Cyrus Ardalan becomes new Chair of IFFIm Board

Ardalan succeeds René Karsenti, who oversaw nearly US$ 2.5 billion in bond issuances, entry into Sukuk markets.

26 October 2017

Malawi MR 2017

23 May 2017

Tedros Adhanom Ghebreyesus

Gavi welcomes election of new WHO Chief

Former Gavi Board member Dr Tedros Adhanom Ghebreyesus is elected Director General of the World Health Organisation (WHO).

close icon

modal window here